T
HZNP

TradeWorx’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

TradeWorx’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-16,809
Closed -$254K – 495
2014
Q1 		$254K Buy
+16,809
New +$190K 0.22% 217

Other funds holding HZNP

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

TradeWorx's HZNP Position: Q2 2014 in Review

TradeWorx sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2014, closing a stake of 16,809 shares — an estimated $254K sold.

TradeWorx first reported a position in HZNP in Q1 2014 and held it in 1 quarter. The position peaked at $254K in Q1 2014. 141 funds tracked by Wall St. Rank hold HZNP as of Q2 2014.

  • TradeWorx reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2014 after selling out during the quarter.
  • TradeWorx sold 16,809 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2014, an estimated $254K.
  • TradeWorx first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 1 quarter.
  • TradeWorx's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $254K in Q1 2014.
  • 141 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2014.

Based on TradeWorx's 13F filing for Q2 2014, filed 10 Jul 2014.